Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dacarbazine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00257205
What this trial is testing

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

Who this might be right for
Melanoma
AstraZeneca 655
Testing effectiveness (Phase 2)Study completedNCT01133977
What this trial is testing

E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma

Who this might be right for
Stage IV Melanoma
Eisai Inc. 97
Early research (Phase 1)Study completedNCT00542893
What this trial is testing

A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine

Who this might be right for
Advanced Melanoma
Genta Incorporated
Testing effectiveness (Phase 2)Ended earlyNCT01692691
What this trial is testing

Dacarbazine and Carmustine in Metastatic Melanoma

Who this might be right for
Melanoma Metastatic
Western Regional Medical Center 1
Testing effectiveness (Phase 2)Ended earlyNCT01705392
What this trial is testing

Bevacizumab vs Dacarbazine in Metastatic Melanoma

Who this might be right for
Metastatic Malignant MelanomaUnresectable Malignant Melanoma
Haukeland University Hospital 2
Large-scale testing (Phase 3)Study completedNCT01763164
What this trial is testing

Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma

Who this might be right for
Metastatic or Unresectable Cutaneous Melanoma
Pfizer 402
Large-scale testing (Phase 3)Study completedNCT00091572
What this trial is testing

Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 859
Large-scale testing (Phase 3)Study completedNCT00003027
What this trial is testing

Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 482
Large-scale testing (Phase 3)Study completedNCT01721772
What this trial is testing

Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 418
Testing effectiveness (Phase 2)Study completedNCT00308607
What this trial is testing

Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
University of Turku 27
Testing effectiveness (Phase 2)Study completedNCT00130442
What this trial is testing

Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
Cellxpert Biotechnology Corp. 134
Testing effectiveness (Phase 2)Looking for participantsNCT06377566
What this trial is testing

BV-AVD in People With Bulky Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 71
Testing effectiveness (Phase 2)Study completedNCT00936221
What this trial is testing

Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients

Who this might be right for
Melanoma
AstraZeneca 385
Testing effectiveness (Phase 2)Ended earlyNCT02190838
What this trial is testing

Comparison of Melatonin or Metformin and Dacarbazine Combination Versus Dacarbazine Alone in Disseminated Melanoma

Who this might be right for
Melanoma
N.N. Petrov National Medical Research Center of Oncology 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT02758717
What this trial is testing

Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage IB Hodgkin LymphomaAnn Arbor Stage II Hodgkin LymphomaAnn Arbor Stage IIA Hodgkin Lymphoma+8 more
Academic and Community Cancer Research United 46
Early research (Phase 1)Study completedNCT00796991
What this trial is testing

Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine

Who this might be right for
Advanced Melanoma
Bristol-Myers Squibb 72
Large-scale testing (Phase 3)Study completedNCT00395070
What this trial is testing

Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma

Who this might be right for
Metastatic Melanoma
Vical 390
Not applicableUnknownNCT00070343
What this trial is testing

Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301

Who this might be right for
Melanoma (Skin)
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04535271
What this trial is testing

Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma

Who this might be right for
Leiomyosarcoma
Sarcoma Oncology Research Center, LLC 80
Large-scale testing (Phase 3)Study completedNCT01327885
What this trial is testing

Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eisai Inc. 452
Next Page